Gender, genetics, and analgesia: understanding the differences in response to pain relief
- PMID: 30519077
- PMCID: PMC6235329
- DOI: 10.2147/JPR.S94650
Gender, genetics, and analgesia: understanding the differences in response to pain relief
Abstract
Genetic variations and gender contribute significantly to the large interpatient variations in opioid-related serious adverse effects and differences in pain relief with other analgesics. Opioids are the most commonly used analgesics to relieve moderate-to-severe postoperative pain. Narrow therapeutic index and unexplained large interpatient variations in opioid-related serious adverse effects and analgesia negatively affect optimal perioperative outcomes. In surgical, experimental, chronic, and neuropathic pain models, females have been reported to have more pain than males. This review focuses on literature evidence of differences in pain relief due to multiple genetic variations and gender of the patient.
Keywords: analgesia; pain; pain genomics; pharmacodynamics; pharmacogenomics; pharmacokinetics.
Conflict of interest statement
Disclosure The authors report no conflicts of interest in this work.
References
-
- Stamer UM, Stüber F, Muders T, Musshoff F. Respiratory depression with tramadol in a patient with renal impairment and CYP2D6 gene duplication. Anesth Analg. 2008;107(3):926–929. - PubMed
-
- Kirchheiner J, Keulen JT, Bauer S, Roots I, Brockmöller J. Effects of the CYP2D6 gene duplication on the pharmacokinetics and phar-macodynamics of tramadol. J Clin Psychopharmacol. 2008;28(1):78–83. - PubMed
-
- Gasche Y, Daali Y, Fathi M, et al. Codeine intoxication associated with ultrarapid CYP2D6 metabolism. N Engl J Med. 2004;351(27):2827–2831. - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
